From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q4 2023 call → NOWe need to determine if management describes a recent transition to being an approved/specified/listed vendor inside buyers' systems, such that future business can arrive without discrete selling events, and that this is new and not yet reflected in results. Scan the transcript. Management discusses customers: AT&T, DISH, Rakuten, Vodafone. They mention "Vodafone as a new customer in 2023" and "Vodafone was the key customer for Continual" (acquired). They say "We are working today with Vodafone as a certified vendor." That suggests being a certified vendor, which could be a form of being on a vendor list. But is that recent? They acquired Continual in 2023, so it's recent. However, does management convey that this status means future business can arrive without discrete selling events? They say "We believe that with the power of RADCOM, the retail product set between us and the wider portfolio, we can further expand with more value." That's about expanding business, not necessarily automatic flow. Also, they say "We are working with a few countries" - so it's early. But the question is about being placed into a buyer's system such that orders come without selling. Being a "certified vendor" might be a qualification, but does management explicitly say that this means orders will flow automatically? They don't say that. They talk about expanding relationships. Also, they mention "multi-year contracts" and "backlog" but that's not about being on a list. The key phrase: "We are working today with Vodafone as a certified vendor." That could be interpreted as being on an approved vendor list. But is it new? Yes, because they acquired Continual in 2023. However, does management convey that this status is recent and that most volume is ahead? They say "we can further expand" and "could scale into a size of Rakuten or even AT&T" - that's potential, not current. But they don't explicitly say that being a certified vendor means orders will come without selling. They also mention "we will expand our focus on our sales activities" - so they still need to sell.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.